July 9 HIV: More info available? I thought the
Post# of 155130
(Total Views: 583)
Posted On: 07/11/2020 4:38:22 PM
July 9 HIV: More info available?
I thought the HIV data that Pourhassan presented on July 9 was pretty good.
Does anyone know of any additional references to the HIV data that was presented?
Is July 9 the only time that data was published?
The monotherapy seemed particularly. The slide in the presentation had about 30 or 40 patients, all of whom achieved viral control at less than 50 copies per milliliter. I think less than 50 copies per milliliter is frequently described as a functional cure.
I understoody Pourhassan to say that there were about 215 patients like those shown in the slide who achivieved less than 50 copies per milliliter within ten weeks of beginning leronlimab monotherapy and sustained that viral suppression to around 50 weeks.
I also thought I heard Pourhassan say that 90% of HIV patients achieved this type of result, so very good but it doesn't work 100%. Of course if its as good as 90%, very little financial impact for CYDY but its a bummer for the 10%.
I also thought Pourhassan said that something like 50 of the 215 patients entered an extension phase of the study and continued to maintain viral suppression for years.
What I really would like is a printed publication summarizing all of this data.
Does anyone know if such a publication exists?
I thought the HIV data that Pourhassan presented on July 9 was pretty good.
Does anyone know of any additional references to the HIV data that was presented?
Is July 9 the only time that data was published?
The monotherapy seemed particularly. The slide in the presentation had about 30 or 40 patients, all of whom achieved viral control at less than 50 copies per milliliter. I think less than 50 copies per milliliter is frequently described as a functional cure.
I understoody Pourhassan to say that there were about 215 patients like those shown in the slide who achivieved less than 50 copies per milliliter within ten weeks of beginning leronlimab monotherapy and sustained that viral suppression to around 50 weeks.
I also thought I heard Pourhassan say that 90% of HIV patients achieved this type of result, so very good but it doesn't work 100%. Of course if its as good as 90%, very little financial impact for CYDY but its a bummer for the 10%.
I also thought Pourhassan said that something like 50 of the 215 patients entered an extension phase of the study and continued to maintain viral suppression for years.
What I really would like is a printed publication summarizing all of this data.
Does anyone know if such a publication exists?
(0)
(0)